2009, ISBN: 9781607614159
[ED: Hardcover], [PU: Humana / Humana Press / Springer, Berlin], With the devastating complication of cancer cells becoming simultaneously resistant to many structurally and mechanistical… Plus…
booklooker.de buecher.de GmbH & Co. KG Frais d'envoiVersandkostenfrei, Versand nach Deutschland. (EUR 0.00) Details... |
2018, ISBN: 9781607614159
[ED: Buch], [PU: Humana Press], Neuware - Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severel… Plus…
booklooker.de |
ISBN: 9781607614159
Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severely limited by multidrug resistance, in that… Plus…
Springer.com Nr. 978-1-60761-415-9. Frais d'envoiWorldwide free shipping, , plus shipping costs. (EUR 0.00) Details... |
ISBN: 9781607614159
Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severely limited by multidrug resistance, in that… Plus…
Springer.com Nr. 978-1-60761-415-9. Frais d'envoiWorldwide free shipping, , DE. (EUR 0.00) Details... |
2009, ISBN: 1607614154
With the devastating complication of cancer cells becoming simultaneously resistant to many structurally and mechanistically unrelated drugs, the efficacy of chemotherapeutic management o… Plus…
Weltbild.de Nr. 20783343. Frais d'envoi, 2-5 Werktage, DE. (EUR 0.00) Details... |
2009, ISBN: 9781607614159
[ED: Hardcover], [PU: Humana / Humana Press / Springer, Berlin], With the devastating complication of cancer cells becoming simultaneously resistant to many structurally and mechanistical… Plus…
2018, ISBN: 9781607614159
[ED: Buch], [PU: Humana Press], Neuware - Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severel… Plus…
ISBN: 9781607614159
Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severely limited by multidrug resistance, in that… Plus…
ISBN: 9781607614159
Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severely limited by multidrug resistance, in that… Plus…
2009, ISBN: 1607614154
With the devastating complication of cancer cells becoming simultaneously resistant to many structurally and mechanistically unrelated drugs, the efficacy of chemotherapeutic management o… Plus…
Données bibliographiques du meilleur livre correspondant
Auteur: | |
Titre: | |
ISBN: |
Informations détaillées sur le livre - Multi-Drug Resistance in Cancer
EAN (ISBN-13): 9781607614159
ISBN (ISBN-10): 1607614154
Version reliée
Date de parution: 2010
Editeur: Humana Press
492 Pages
Poids: 1,267 kg
Langue: eng/Englisch
Livre dans la base de données depuis 2009-10-17T19:26:40+02:00 (Paris)
Page de détail modifiée en dernier sur 2024-03-13T10:41:56+01:00 (Paris)
ISBN/EAN: 1607614154
ISBN - Autres types d'écriture:
1-60761-415-4, 978-1-60761-415-9
Autres types d'écriture et termes associés:
Auteur du livre: zhou, jun, sierk
Titre du livre: resistance, cancer
Données de l'éditeur
Auteur: Jun Zhou
Titre: Methods in Molecular Biology; Multi-Drug Resistance in Cancer
Editeur: Humana; Humana Press
492 Pages
Date de parution: 2009-11-18
Totowa; NJ; US
Imprimé / Fabriqué en
Poids: 1,250 kg
Langue: Anglais
106,99 € (DE)
109,99 € (AT)
118,00 CHF (CH)
POD
XII, 492 p. 67 illus., 4 illus. in color.
BB; Oncology; Hardcover, Softcover / Medizin/Klinische Fächer; Onkologie; Verstehen; ATP-binding; Cancer stem cells; Chemotherapy; Drug transporter function; P-glycoproteins; Regulation; Resistance reversal agents; tissue; antibacterial drug resistance; Cancer Research; Drug Resistance; Oncology; Cancer Biology; Medical Microbiology; Mikrobiologie und Virologie; BC; EA
1. Multidrug Resistance in Cancer Bruce C. Baguley 2. Multidrug Resistance in Oncology and Beyond: From Imaging of Drug Efflux Pumps to Cellular Drug Targets Wouter B. Nagengast, Thijs H. Oude Munnink, Eli C.F. Dijkers, Geke A.P. Hospers, Adrienne H. Brouwers, Carolien P. Schröder, Marjolijn Lub-de Hooge, and Elisabeth G.E. de Vries 3. Studying Drug Resistance Using Genetically Engineered Mouse Models for Breast Cancer Sven Rottenberg, Marina Pajic, and Jos Jonkers 4. Mechanisms of Multidrug Resistance in Cancer Jean-Pierre Gillet and Michael M. Gottesman 5. Molecular Mechanisms of Drug Resistance in Single-Step and Multi-Step Drug-Selected Cancer Cells Anna Maria Calcagno and Suresh V. Ambudkar 6. Pharmacogenetics of ATP-Binding Cassette Transporters and Clinical Implications Ingolf Cascorbi and Sierk Haenisch 7. Flow Cytometric Evaluation of Multidrug Resistance Proteins Adorjan Aszalos and Barbara J. Taylor 8. Targeted Chemotherapy in Drug Resistant Tumors and Noninvasive Imaging of P-Glycoprotein-Mediated Functional Transport in Cancer Jothilingam Sivapackiam, Seth T. Gammon, Scott E. Harpstrite, and Vijay Sharma 9. Epigenetic Regulation of Multidrug Resistance 1 Gene Expression: Profiling CpG Methylation Status Using Bisulphite Sequencing Emma K. Baker and Assam El-Osta 10. Expression and Function of P-Glycoprotein in Normal Tissues: Effect on Pharmacokinetics Frantisek Staud, Martina Ceckova, Stanislav Micuda, and Petr Pavek 11. Molecular Mechanism of ATP-Dependent Solute Transport by Multidrug Resistance-Associated Protein 1 Xiu-bao Chang 12. Impact of Breast Cancer Resistance Protein on Cancer Treatment Outcomes Douglas D. Ross and Takeo Nakanishi 13. Drug Ratio-Dependent Antagonism: A NewCategory of Multidrug Resistance and Strategies for Its Circumvention Troy O. Harasym, Barry D. Liboiron, and Lawrence D. Mayer 14. Reversing Agents for ATP-Binding Cassette Drug Transporters Chow H. Lee 15. Overcoming Multidrug Resistance in Cancer: Clinical Studies of P-Glycoprotein Inhibitors Helen M. Coley 16. Pharmacokinetic and Pharmacodynamic Implications of P-Glycoprotein Modulation Jeannie M. Padowski and Gary M. Pollack 17. Examination of CYP3A and P-Glycoprotein-Mediated Drug-Drug Interactions Using Animal Models Punit H. Marathe and A. David Rodrigues 18. Generating Inhibitors of P-Glycoprotein: Where to, Now? Emily Crowley, Christopher A. McDevitt, and Richard Callaghan 19. Immunosuppressors as Multidrug Resistance Reversal Agents Hamid Morjani and Claudie Madoulet 20. Overcoming Multidrug Resistance by RNA Interference Alexandra Stege, Andrea Krühn, and Hermann Lage 21. Circumventing Tumor Resistance to Chemotherapy by Nanotechnology Xing-Jie Liang, Chunying Chen, Yuliang Zhao, and Paul C. WangAutres livres qui pourraient ressembler au livre recherché:
Dernier livre similaire:
9781607614166 Multi-Drug Resistance in Cancer (Jun Zhou)
< pour archiver...